Cargando…

ACE polymorphisms and COVID-19-related mortality in Europe

Detalles Bibliográficos
Autores principales:	Bellone, Matteo, Calvisi, Stefania Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491982/ https://www.ncbi.nlm.nih.gov/pubmed/32935155 http://dx.doi.org/10.1007/s00109-020-01981-0

Ejemplares similares

ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010)

COVID-19, diabetes mellitus and ACE2: The conundrum
por: Pal, Rimesh, et al.
Publicado: (2020)

The impact of COVID-19 on primary care in Europe
por: Mughal, Faraz, et al.
Publicado: (2021)

Relationship between the Prevalence of ACE1 I/D Polymorphism Genotype II and Covid-19 Morbidity, Mortality in Ukraine and in Some Europe Countries
por: Livshits, L. A., et al.
Publicado: (2021)

ACE polymorphism and COVID-19 outcome
por: Delanghe, Joris R., et al.
Publicado: (2020)

COVID-19 Fear in Eastern Europe: Validation of the Fear of COVID-19 Scale
por: Reznik, Alexander, et al.
Publicado: (2020)

Geographical differences on the mortality impact of heat waves in Europe
por: Sunyer, Jordi
Publicado: (2010)

The Role of ACE, ACE2, and AGTR2 Polymorphisms in COVID-19 Severity and the Presence of COVID-19-Related Retinopathy
por: Jevnikar, Kristina, et al.
Publicado: (2022)

Differential expression of ACE2 in the respiratory tracts and its relationship to COVID-19 pathogenesis
por: Yang, Chunxiu, et al.
Publicado: (2020)

The duplicitous nature of ACE2 in COVID-19 disease EBioMedicine (invited commentary)
por: Heyman, Samuel N., et al.
Publicado: (2021)

ACE I/D polymorphism and epidemiological findings for COVID-19: One year after the pandemic outbreak in Europe
por: Ristić, Smiljana, et al.
Publicado: (2021)

Maximising public adherence to COVID-19 self-isolation in Europe
por: Patel, Jay, et al.
Publicado: (2021)

Regulating the health workforce in Europe: implications of the COVID-19 pandemic
por: Panteli, Dimitra, et al.
Publicado: (2021)

SARS‐CoV‐2 first contact: Spike–ACE2 interactions in COVID‐19
por: Nesci, Salvatore
Publicado: (2021)

The Relation between ACE Gene Polymorphism and the Severity of COVID-19 Infection
por: El-Sayed Marei, Yara, et al.
Publicado: (2023)

Is BCG vaccination causally related to reduced COVID‐19 mortality?
por: Miyasaka, Masayuki
Publicado: (2020)

ACE2: The Key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?
por: Xiao, Li, et al.
Publicado: (2020)

Evidencing the detrimental impact of the COVID-19 pandemic on mental health across Europe
por: Webb, Roger T, et al.
Publicado: (2021)

Polymorphous acral eruption and Covid-19
por: Elkhachine, Youness, et al.
Publicado: (2020)

Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease
por: Sabater Molina, Maria, et al.
Publicado: (2022)

COVID-19 susceptibility: potential of ACE2 polymorphisms
por: Chaudhary, Mayank
Publicado: (2020)

Suggestions from Cremona, Italy: 2 months into the pandemic at the frontline of COVID-19 in Europe
por: Pan, A., et al.
Publicado: (2020)

It’s X-Related: Biological Bases of Increased COVID-19 Morbidity and Mortality in Men
por: Angelides, Philip K, et al.
Publicado: (2020)

Association investigations between ACE1 and ACE2 polymorphisms and severity of COVID-19 disease
por: Najafi, Mojtaba, et al.
Publicado: (2022)

Bacillus Calmette–Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality
por: Osama El-Gendy, Ahmed, et al.
Publicado: (2020)

ACE2 polymorphisms as potential players in COVID-19 outcome
por: Khayat, André Salim, et al.
Publicado: (2020)

Pharmacists’ involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy
por: Paudyal, Vibhu, et al.
Publicado: (2021)

Confronting the burden of tobacco-related lung cancer in Europe in the next decades
por: ten Haaf, Kevin
Publicado: (2021)

Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D
por: La Vignera, Sandro, et al.
Publicado: (2020)

The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19
por: Bosso, Mira, et al.
Publicado: (2020)

Dose response of ACE inhibitors: implications of the SECURE trial
por: Lonn, Eva
Publicado: (2001)

Does hydroxychloroquine reduce mortality for COVID-19?
por: GALLUS, Silvano, et al.
Publicado: (2020)

Benefits of future clean air policies in Europe: Proposed analyses of the mortality impacts of PM(2.5) and NO(2)
por: Hoffmann, Barbara, et al.
Publicado: (2022)

Commentary on “The Ukrainian refugee crisis and the COVID-19 pandemic in Europe” (Int J Surg 2022;102:106671)
por: Sriwitalai, Won, et al.
Publicado: (2022)

The impact of air pollution on the incidence and mortality of COVID-19
por: Karan, Abhinav, et al.
Publicado: (2020)

Trend towards reduction in COVID-19 in-hospital mortality
por: Ruggeri, Annalisa, et al.
Publicado: (2021)

Ideal body mass index determined by mortality in Europe, and adequate high protein and low carbohydrate diet to maintain bodyweight
por: Shirai, Kohji
Publicado: (2011)

miR-200c-3p upregulation and ACE2 downregulation via bacterial LPS and LTA as interesting aspects for COVID-19 treatment and immunity
por: Soltani, Saber, et al.
Publicado: (2021)

Effects of PM2.5 Exposure on the ACE/ACE2 Pathway: Possible Implication in COVID-19 Pandemic
por: Botto, Laura, et al.
Publicado: (2023)

Investigating the ACE2 polymorphisms in COVID‐19 susceptibility: An in silico analysis
por: Pouladi, Nasser, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_29n8mqjjdkib6iho38s3esdlc2